Nuclear Medicine and Biology
Volume 35, Issue 6 , Pages 707-712, August 2008

In vitro evaluation of canine leukocytes radiolabeled in whole blood with 99mTc stannous colloid

  • Mohamed H. Abushhiwa

      Affiliations

    • Faculty of Veterinary Science, The University of Melbourne, Werribee, Victoria 3030, Australia
    • Corresponding Author InformationCorresponding author. Tel.: +61 3 9731 2060; fax: +61 3 9731 2246.
  • ,
  • Nouria S. Salehi

      Affiliations

    • Department of Nuclear Medicine, Royal Melbourne Hospital, Parkville, Victoria 3052, Australia
  • ,
  • Robert C. Whitton

      Affiliations

    • Faculty of Veterinary Science, The University of Melbourne, Werribee, Victoria 3030, Australia
  • ,
  • Jennifer A. Charles

      Affiliations

    • Faculty of Veterinary Science, The University of Melbourne, Werribee, Victoria 3030, Australia
  • ,
  • Peter J. Finnin

      Affiliations

    • Faculty of Veterinary Science, The University of Melbourne, Werribee, Victoria 3030, Australia
  • ,
  • Peter M. Lording

      Affiliations

    • Faculty of Veterinary Science, The University of Melbourne, Werribee, Victoria 3030, Australia
  • ,
  • Ivan W. Caple

      Affiliations

    • Faculty of Veterinary Science, The University of Melbourne, Werribee, Victoria 3030, Australia
  • ,
  • Bruce W. Parry

      Affiliations

    • Faculty of Veterinary Science, The University of Melbourne, Werribee, Victoria 3030, Australia

Received 8 April 2008; accepted 29 April 2008. published online 01 July 2008.

Abstract 

Introduction

Technetium-99m stannous colloid (99mTcSnC)-labeled leukocytes are used to investigate a variety of inflammatory diseases in human medicine. The present study investigates the in vitro behavior of canine leukocytes labeled in whole blood with 99mTcSnC.

Methods

Blood samples from 10 healthy dogs were labeled with 99mTcSnC using a standard procedure. The distribution of radioactivity among blood components (plasma, leukocyte layers and erythrocytes) was measured following separation of the radiolabeled samples across Histopaque density gradients. Phagocytic function of labeled and unlabeled leukocytes was estimated using zymosan particles. Labeling retention by leukocytes was determined at 1, 3, 4 and 7 h postlabeling.

Results

The mean±standard error percentage of radioactivity associated with plasma, erythrocyte and leukocyte fractions was 2.0±0.21%, 55.5±0.60% and 42.5±0.54%, respectively (the last comprising 70.2±0.83% in polymorphonuclear leukocytes and 29.8±0.83% in mononuclear leukocytes). Labeled canine leukocytes had a phagocytic activity of 91.3±0.28% (control, 91.7±0.26%). The radiolabeled canine leukocytes retained 94.1±0.30% of radioactivity at 7 h postlabeling.

Conclusions

Radiolabeling of canine leukocytes in whole blood with 99mTcSnC has minor adverse effect on their phagocytic function. The radiolabeled canine leukocytes retained a large percentage of radioactivity for at least 7 h postlabeling.

Keywords: 99mTcSnC, Radiolabeling canine leukocytes, Labeling efficiency, Phagocytic function, Labeling retention

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0969-8051(08)00106-6

doi:10.1016/j.nucmedbio.2008.04.009

Nuclear Medicine and Biology
Volume 35, Issue 6 , Pages 707-712, August 2008